Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

Cited by (1,011)

Items 701–800 of 1,011

1. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome
   Guilherme Ramires de Jesús, Ashley E. Benson, Cecilia Beatrice Chighizola, Savino Sciascia, David Ware Branch · 2020 · Lupus
2. Intestinal microbiota and active systemic lupus erythematosus: a systematic review
   Juliana Rosa Pires Vieira, Andréa Toledo de Oliveira Rezende, Marcos Rassi Fernandes, Nílzio Antônio da Silva · 2021 · Revista Brasileira de Reumatologia
3. The Emergence of new-onset SLE following SARS-CoV-2 vaccination
   Arvind Nune, Karthikeyan Parthasarathy Iyengar, Pranav Ish, B Varupula, C. A. Musat, Hem Raj Sapkota · 2021 · QJM
4. Differential diagnosis of systemic lupus erythematosus and Sjögren's syndrome using machine learning and multi-omics data
   Jordi Martorell‐Marugán, Marco Chierici, Giuseppe Jurman, Marta Eugenia Alarcón-Riquelme, Pedro Carmona‐Sáez · 2022 · Computers in Biology and Medicine
5. Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus
   Amanda M. Eudy, Malithi Jayasundara, Tayseer Haroun, Laura Neil, Allison James, Megan E. B. Clowse · 2017 · Lupus
6. Systematic review of anti-dsDNA testing for systemic lupus erythematosus: a meta-analysis of the diagnostic test specificity of an anti-dsDNA fluorescence enzyme immunoassay
   Orme, Michelle E., Voreck, Anja, Aksouh, Redha, Ramsey-Goldman, Rosalind, Schreurs, Marco W.J. · 2021 · Autoimmunity Reviews
7. Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry
   Yusuke Miyazaki, Masashi Funada, Shingo Nakayamada, Koshiro Sonomoto, Hiroaki Tanaka, Kentaro Hanami, Shunsuke Fukuyo, Satoshi Kubo, Ayako Yamaguchi, Ippei Miyagawa et al. · 2023 · Rheumatology
8. Different expression patterns and clinical significance of mAxl and sAxl in systemic lupus erythematosus
   Huaqun Zhu, X Sun, Lei Zhu, Fanlei Hu, Lianjie Shi, C Fan, Zhanguo Li, Y Su · 2014 · Lupus
9. Old lines tell new tales: Blaschko linear lupus erythematosis
   Hui Jin, Guiying Zhang, Ying Zhou, Christopher Chang, Qianjin Lu · 2015 · Autoimmunity Reviews
10. Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia
    Ekarat Rattarittamrong, Prot Eiamprapai, Adisak Tantiworawit, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai‐Adisaksopha, Lalita Norasetthada · 2016 · Hematology
11. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death
    Cristina Arriens, Sixia Chen, David R. Karp, Ramesh Saxena, Kamalanathan Kolandavelu Sambandam, Eliza F. Chakravarty, Judith A. James, Joan T. Merrill · 2016 · Clinical Immunology
12. Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis
    Hanna Lythgoe, T A Morgan, Eleanor Heaf, Olivia Lloyd, Eslam Al‐Abadi, Kate Armon, Kathryn M. Bailey, Joyce E Davidson, Mark Friswell, J Gardner-Medwin et al. · 2017 · Lupus
13. Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study
    Sylvia J. Kroese, Carolien N. H. Abheiden, Birgit S. Blomjous, Jacob M. van Laar, Ronald H. W. M. Derksen, Irene E. M. Bultink, Alexandre E. Voskuyl, A. Titia Lely, Marjon Alina de Boer, Johanna I.P. de Vries et al. · 2017 · Journal of Immunology Research
14. Changing antimalarial agents after inefficacy or intolerance in patients with cutaneous lupus erythematosus: A multicenter observational study
    François Chasset, Laurent Arnaud, Marie Jachiet, J.‐B. Monfort, Jean‐David Bouaziz, F. Cordoliani, Martine Bagot, Annick M. Barbaud, Camille Francès · 2017 · Journal of the American Academy of Dermatology
15. Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL
    Ioannis Parodis, F Söder, Francesca Faustini, Zsolt Kasza, Isak Samuelsson, Agneta Zickert, Elisabet Svenungsson, Ronald van Vollenhoven, Vivianne Malmström, Fredrik Wermeling et al. · 2018 · Lupus
16. Prognostic nutritional index is correlated with disease activity in patients with systemic lupus erythematosus
    Sung Soo Ahn, Seung Min Jung, Jason Jungsik Song, Y-B Park, S-W Lee · 2018 · Lupus
17. The Utilization of Autoantibodies in Approaches to Precision Health
    Marvin J. Fritzler, Laura Martínez-Prat, May Y. Choi, Michael Mähler · 2018 · Frontiers in Immunology
18. RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children
    Wei Wang, Yu Ling Zhou, Linqing Zhong, Lin Wang, Xiaoyan Tang, Mingsheng Ma, Ji Li, Hongmei Song · 2019 · Pediatric Rheumatology
19. Autoantibodies in SLE: prediction and the p value matrix
    May Y. Choi, Marvin J. Fritzler · 2019 · Lupus
20. Mental disorders in systemic lupus erythematosus: a cohort study
    Heidi Ángela Fernández, Andrea Carolina Cevallos Teneda, Ruth Jimbo-Sotomayor, Fernando Naranjo-Saltos, Diego Mera Orcés, Efrain Basantes · 2019 · Rheumatology International
21. The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation †
    Belén Atienza‐Mateo, Sara Remuzgo‐Martínez, Víctor Manuel Mora Cuesta, David Iturbe Fernandez, Sonia Fernández-Rozas, Diana Prieto-Pena, Monica Calderón-Goercke, Alfonso Corrales, Gerardo Blanco Rodríguez, Javier Gómez‐Román et al. · 2020 · Journal of Clinical Medicine
22. Racial Disparities in Medication Adherence between African American and Caucasian Patients With Systemic Lupus Erythematosus and Their Associated Factors
    Kai Sun, Amanda M. Eudy, Lisa G. Criscione‐Schreiber, Rebecca E. Sadun, Jennifer L Rogers, Jayanth Doss, Amy L. Corneli, Hayden Barry Bosworth, Megan E. B. Clowse · 2020 · ACR Open Rheumatology
23. ‘But you don’t look sick’: a qualitative analysis of the LUPUS UK online forum
    Melanie A Sloan, Michael Bosley, Moira Blane, Lynn Holloway, Colette Barrere, David P. D’Cruz, Chanpreet Walia, Felix Naughton, Paul D. Howard, Stephen R. Sutton et al. · 2020 · Rheumatology International
24. Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review
    Huaxia Yang, Huazhen Liu, Ziyue Zhou, Lidan Zhao, Yunyun Fei, Hua Chen, Fengchun Zhang, Xuan Zhang · 2020 · Clinical Reviews in Allergy & Immunology
25. From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers
    Wietske M. Lambers, Johanna Westra, Hendrika Bootsma, Karina de Leeuw · 2020 · Seminars in Arthritis and Rheumatism
26. Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden
    Thomas Pincez, Helder Fernandes, Thierry M Leblanc, Gérard Michel, Vincent Barlogis, Yves Bertrand, Bénédicte Neven, Wadih Abou Chahla, Marlène Pasquet, Corinne Guitton et al. · 2021 · Haematologica
27. Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis
    Guillermo Ruiz‐Irastorza, Luis Dueña-Bartolomé, Susanna Dunder, Jimena Varona, Carlota Gómez-Carballo, Jokin Dominguez-Cainzos, Alejandro Rodrigo-Manjon, Laura Bueno, Christophe Richez, P. Duffau et al. · 2021 · Autoimmunity Reviews
28. Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
    Ronald van Vollenhoven, Bevra Hannahs Hahn, George C. Tsokos, Peter E. Lipsky, Robert M. Gordon, Kaiyin Fei, Kim Hung Lo, Marc R. Chevrier, Shawn M. Rose, Pamela Berry et al. · 2021 · The Journal of Rheumatology
29. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    Tatiana Magomedalievna Reshetnyak, Kamila S. Nurbaeva, Ivan V. Ptashnik, Anna A. Kudriaeva, Alexey A. Belogurov, Aleksandr M. Lila, Evgeny Lvovich Nasonov · 2023 · International Journal of Molecular Sciences
30. Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma
    Chingching Foocharoen, Sittichai Netwijitpan, Ajanee Mahakkanukrauh, Siraphop Suwannaroj, Ratanavadee Nanagara · 2016 · International Journal of Rheumatic Diseases
31. Immunogenetics of cutaneous lupus erythematosus
    Aimee O. Hersh, Lisa M. Arkin, Sampath Prahalad · 2016 · Current Opinion in Pediatrics
32. Neuropsychiatric lupus
    Claudia Centurión-Wenninger · 2021 · Revista Paraguaya de Reumatología
33. New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS
    Florence Assan, Raphaèle Séror, Xavier Mariette, Gaëtane Nocturne · 2019 · Annals of the Rheumatic Diseases
34. Circulating exosomal microRNAs as biomarkers of lupus nephritis
    Fei Chen, Bo Shi, Wenjing Liu, Jianmin Gong, Jia Gao, Yifan Sun, Ping Yang · 2023 · Frontiers in Immunology
35. Low-density granulocytes and neutrophil extracellular trap formation are increased in incomplete systemic lupus erythematosus
    Svenja Henning, Tobias Reimers, Wayel Habib Abdulahad, Juan J. Fierro, Berber Doornbos‐van der Meer, Hendrika Bootsma, Barbara Horváth, Karina de Leeuw, Johanna Westra · 2024 · Rheumatology
36. Precision Medicine in Rheumatology: The Role of Biomarkers in Diagnosis and Treatment Optimization
    Matteo Colina, Gabriele Campana · 2025 · Journal of Clinical Medicine
37. Heterogeneity between Diagnostic Tests for IgA anti-Beta2 Glycoprotein I: Explaining the Controversy in Studies of Association with Vascular Pathology
    José A. Martínez-Flores, Manuel Serrano, Javier Alfaro, Sergio Castro Mora, Estela Paz‐Artal, José Morales, Antonio Serrano · 2013 · Analytical Chemistry
38. Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case–control study
    Susan Tadros, Andrew J. Teichtahl, Sabina Ciciriello, Ian P. Wicks · 2016 · Seminars in Arthritis and Rheumatism
39. Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren’s Syndrome
    Ellen De Langhe, Xavier Bossuyt, Long Shen, Kishore S. Malyavantham, Julian L. Ambrus, Lakshmanan Suresh · 2017 · The Open Rheumatology Journal
40. Polyserositis: a diagnostic challenge
    Inés Asunción Losada López, Juan González‐Moreno, Nuria Roda, Lola Ventayol‐Aguiló, Yolanda Borjas, Francisco Javier Domínguez Valdés, Victoria Fernández‐Baca, Mercedes García‐Gasalla, Antoni Payeras · 2018 · Internal Medicine Journal
41. Steroid-free remission in lupus: myth or reality; an observational study from a tertiary referral centre
    Rudra Prosad Goswami, Hiramanik Sit, Parasar Ghosh, Geetabali Sircar, Alakendu Ghosh · 2018 · Clinical Rheumatology
42. Structural and functional brain connectomes in patients with systemic lupus erythematosus
    Paolo Preziosa, Maria Assunta Rocca, Giuseppe Alvise Ramirez, Enrica Paola Bozzolo, Valentina Canti, Elisabetta Pagani, Paola Valsasina, Lucia Moiola, Patrizia Querini Rovere, A. Manfredi et al. · 2019 · European Journal of Neurology
43. Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease
    Beatrice Rivalta, Daniele Zama, Giovanni Pancaldi, Elena Facchini, Maria Elena Cantarini, Angela Miniaci, Arcangelo Prete, Andrea Pession · 2019 · Frontiers in Pediatrics
44. Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity
    Hakan Babaoğlu, Jessica Li, DANIEL W. GOLDMAN, Laurence S. Magder, Michelle Petri · 2019 · Arthritis Care & Research
45. Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease
    Patrizia Leone, Sebastiano Cicco, Marcella Prete, Antonio Giovanni Solimando, Nicola Susca, Lucilla Crudele, Alessio Buonavoglia, Paolo Colonna, Franco Dammacco, Angelo Vacca et al. · 2019 · Clinical and Experimental Medicine
46. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers
    François Chasset, Camillo Ribi, Marten Trendelenburg, Uyen Huynh‐Do, Pascale Roux‐Lombard, Delphine Sophie Courvoisier, Carlo Chizzolini, for the Swiss SLE Cohort Study (SSCS · 2020 · Rheumatology
47. Left Ventricular Systolic Function in Patients with Systemic Lupus Erythematosus and Its Association with Cardiovascular Events
    Tea Gegenava, Maka Gegenava, Gerda M. Steup‐Beekman, Tom W. J. Huizinga, Jeroen Joost Bax, Victoria Delgado, Nina Ajmone Marsan · 2020 · Journal of the American Society of Echocardiography
48. Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases
    Dao-Ping Sun, Wen-Ming Chen, Li Wang, Zhen Wang, Jin‐Hua Liang, Huayuan Zhu, Lei Fan, Yujie Wu, Wei Xu, Jianyong Li · 2021 · Journal of Cancer Research and Clinical Oncology
49. Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study
    Rangi Kandane‐Rathnayake, Worawit Louthrenoo, Vera Golder, Shue‐Fen Luo, Yeong‐Jian Jan Wu, Aisha Lateef, Jiacai Cho, Zhanguo Li, Yuan An, Laniyati Hamijoyo et al. · 2021 · Rheumatology
50. Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?—observations from the UK JSLE Cohort Study
    Eve M D Smith, Sajida Rasul, Coziana Ciurtin, Eslam Al‐Abadi, Kate Armon, Kathryn M. Bailey, Mary Brennan, Janet M. Gardner-Medwin, Kirsty Haslam, Daniel Philip Hawley et al. · 2021 · Rheumatology
51. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice
    Lingling Wu, Xiaoyue Jiang, Chaojun Qi, Chunyan Zhang, Bo Qu, Nan Shen · 2021 · Frontiers in Immunology
52. Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19
    Cláudia Gomes, Marisol Zuniga, Kelly A Crotty, Kun Qian, Nubia Catalina Tovar, Lawrence Hsu Lin, Kimon V. Argyropoulos, Robert M. Clancy, Peter Izmirly, Jill P. Buyon et al. · 2021 · Life Science Alliance
53. Definition of low disease activity state based on the SLE-DAS: derivation and validation in a multicentre real-life cohort
    Helena Assunção, Diogo Jesús, Maddalena Larosa, Carla Henriques, Ana Cristina Matos, Véronique Le Guern, Francisco J. Rubiño, José António Pereira da Silva, Íñigo Rúa‐Figueroa, Nathalie Costedoat-Chalumeau et al. · 2021 · Rheumatology
54. The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact—A System Criticism and a Hypothesis
    Ole Petter Rekvig · 2022 · Frontiers in Immunology
55. Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus
    Hanane El Bannoudi, MacIntosh Cornwell, Elliot S Luttrell-Williams, Alexis Engel, Christina Charlotte Rolling, Tessa J. Barrett, Peter Izmirly, Michael H Belmont, Kelly V. Ruggles, Robert M. Clancy et al. · 2022 · Arthritis & Rheumatology
56. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus
    Duygu Eryavuz Onmaz, Dilek Tezcan, Sema Yi̇lmaz, Mustafa Onmaz, Ali Ünlü · 2023 · Amino Acids
57. Autoimmune Liver Diseases and Antiphospholipid Antibodies Positivity: a Meta-analysis of Literature Studies
    Pasquale Ambrosino, Roberta Lupoli, Gaia Spadarella, Paolo Tarantino, Alessandro Di Minno, Luciano Tarantino, Matteo Nicola Dario Di Minno · 2015 · Journal of Gastrointestinal and Liver Diseases
58. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus
    Shereen Oon, Huy Huynh, Tsin Yee Tai, Milica Ng, Katherine Monaghan, Mark Biondo, Gino Vairo, Eugene Maraskovsky, Andrew D. Nash, Ian P. Wicks et al. · 2016 · JCI Insight
59. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort
    SRIKANTH VEMULAPALLI, L Cohen, Vivien M Hsu · 2016 · Scandinavian Journal of Rheumatology
60. Concerns of patients with systemic lupus erythematosus and adherence to therapy – a qualitative study
    Filipa Farinha, Francisco Freitas, Ana Filipa águeda, Maria Inês Cunha, Anabela Barcelos · 2017 · Patient Preference and Adherence
61. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review
    Isabel S. Bazan, Kofi A. Mensah, Anastasiia A. Rudkovskaia, Percy Adonteng-Boateng, Erica L. Herzog, Lenore M. Buckley, Wassim H. Fares · 2017 · Respiratory Medicine
62. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
    Ruth Fernandez‐Ruiz, Nicole Bornkamp, Mimi Kim, Anca Askanase, Anna Zezon, Chung-E Tseng, Michael H Belmont, Amit Saxena, Jane E. Salmon, Michael D. Lockshin et al. · 2020 · Arthritis Research & Therapy
63. Clinical aspects of cutaneous lupus erythematosus
    Julia K. Elmgren, Filippa Nyberg · 2023 · Frontiers in Medicine
64. The Challenge of Neuropsychiatric Systemic Lupus Erythematosus: From Symptoms to Therapeutic Strategies
    Veena Patel · 2024 · Diagnostics
65. Vitamin D status in children with systemic lupus erythematosus and its association with clinical and laboratory parameters
    Alhanouf AlSaleem, Ashwaq Ahmed AlE'ed, Afaf AlSaghier, Sulaiman Mohammed Al-Mayouf · 2014 · Clinical Rheumatology
66. Belimumab in systemic lupus erythematosus
    Andreia Vilas‐Boas, Sandra A. Morais, David Alan Isenberg · 2015 · RMD Open
67. New insights into the pathogenesis and management of lupus in children
    Angela Midgley, L. Watson, Michael William Beresford · 2014 · Archives of Disease in Childhood
68. Gastrointestinal system manifestations in juvenile systemic lupus erythematosus
    Hafize Emine Sönmez, Asuman Nur Karhan, Ezgi Deniz Batu, Yelda Bilginer, Ersin Gümüş, Hülya Demır, Aysel Yüce, Seza Özen · 2017 · Clinical Rheumatology
69. Ischemic stroke as initial manifestation of systemic lupus erythematosus: A case report and review of the literature
    Stefanos G. Ioannidis, Michael Mavridis, Panayiotis D. Mitsias · 2018 · eNeurologicalSci
70. Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis
    Sajal Ajmani, Harshit Singh, Saurabh Chaturvedi, Ravi Mishra, Mohit Kumar Rai, Avinash Jain, Durga Prasanna Misra, Vikas Agarwal · 2018 · Clinical Rheumatology
71. Systemic Lupus Erythematosus and Pregnancy: A Brief Review
    Deepan S. Dalal, Khyati Patel, Madhuri Arvind Patel · 2019 · The Journal of Obstetrics and Gynecology of India
72. Epilepsy in systemic lupus erythematosus: prevalence and risk factors
    L Hopia, Magnus Andersson, Elisabet Svenungsson, Mohsen Khademi, Fredrik Piehl, Torbjörn Tomson · 2019 · European Journal of Neurology
73. An Update on Antibodies to Necleosome Components as Biomarkers of Sistemic Lupus Erythematosus and of Lupus Flares
    Gian Marco Ghiggeri, Matteo D’Alessandro, Domenico Bartolomeo, Maria Ludovica Degl’Innocenti, Alberto Magnasco, Francesca Lugani, Marco Prunotto, Maurizio Bruschi · 2019 · International Journal of Molecular Sciences
74. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome
    Chuiwen Deng, Yingying Chen, Wenli Li, Linyi Peng, Xuan Luo, Yu Peng, Lidan Zhao, Qingjun Wu, Wen Zhang, Xuan Zhang et al. · 2020 · Journal of Autoimmunity
75. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study
    Stylianos Panopoulos, Κonstantinos Thomas, Georgios A. Georgiopoulos, Dimitrios T. Boumpas, Christina G. Katsiari, George K Bertsias, Alexandros A. Drosos, Kyriaki A. Boki, Theodoros Dimitroulas, Alexandros Garyfallos et al. · 2020 · Rheumatology
76. Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study
    Valéria Valim, Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, Arthur Dalmaso Pinto, Priscila Costa Martins Rocha, Érica Vieira Serrano, Valquíria Garcia Dinis, Sônia Alves Gouvêa, João Gabriel Fragoso Dias, Ana Carolina Campi‐Azevedo et al. · 2020 · Frontiers in Immunology
77. Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort
    Manish Rathi, Parmeshar Singh, Hayath Peta Bi, Archana Shivanna, Chengappa G. Kavadichanda, Saumya Ranjan Tripathy, Janani Parthasarathy, Sneha Tota, Supriya Maurya, Vishnupriya Vijayalekshmi et al. · 2020 · Lupus
78. Associations of metabolic syndrome in SLE
    Diane Apostolopoulos, Fabien B. Vincent, Alberta Yik-Bun Hoi, Eric Francis Morand · 2020 · Lupus Science & Medicine
79. Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments
    Marc Scherlinger, Johanna Lutz, Gaël Galli, Christophe Richez, Jacques‐Eric Gottenberg, Jean Sibilia, Laurent Arnaud, Patrick Blanco, Thierry Schaeverbeke, Emmanuel Chatelus et al. · 2020 · Seminars in Arthritis and Rheumatism
80. Myocardial Infarction in Systemic Lupus Erythematosus: Incidence and Coronary Angiography Findings
    Per Tornvall, Alexandra Göransson, Julia Ekman, Hans Järnbert‐Pettersson · 2021 · Angiology
81. Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
    Syahrul Sazliyana Shaharir, Siew Houy Chua, Rozita Mohd, Ruslinda Mustafar, Malehah Mohd Noh, Nor Shuhaila Shahril, Mohd Shahrir Mohamed Said, Rajalingham Sakthiswary · 2021 · PLoS ONE
82. Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre
    Deanna D. Hill, Amanda M. Eudy, P. Egger, Qinggong Fu, Michelle Petri · 2021 · Lupus Science & Medicine
83. Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases
    Paul Decker, T. Moulinet, Benjamín López, Sylvain Dubucquoi, Bernard Bonnotte, Daniela Lakomy, Sabine Revuz, Amandine Luc, Marcelo De Carvalho Bittencourt, Eric HACHULLA et al. · 2021 · European Journal of Internal Medicine
84. Erosive arthritis in systemic lupus erythematosus: not only Rhupus
    Fulvia Ceccarelli, Francesco Natalucci, Giulio Olivieri, Carlo Perricone, Carmelo Pirone, Francesca Romana Spinelli, Cristiano Alessandri, Fabrizio Conti · 2021 · Lupus
85. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients
    Wafa Ammouri, Harmouche Hicham, Radi Naoufal, Khibri Hajar, Rachid Razıne, Souad Benkirane, M. Maamar, Zoubida Mezalek Tazi, Adnaoui Mohamed · 2022 · Clinical Rheumatology
86. Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus
    Joyce J. B. C. van Beers, Marco W.J. Schreurs · 2022 · Journal of Translational Autoimmunity
87. Improvement in Cutaneous Lupus Erythematosus After Twenty Weeks of Belimumab Use: A Systematic Review and Meta‐Analysis
    Rachel Kneeland, Daniel Montes, Justin O Endo, Bridget E. Shields, Christie Michels Bartels, Shivani Garg · 2022 · Arthritis Care & Research
88. Laser Therapy in the Treatment of Connective Tissue Diseases: A Review
    Jeremy A. Brauer, Elizabeth A Gordon Spratt, Roy G. Geronemus · 2013 · Dermatologic Surgery
89. Endothelial Dysfunction in Early Systemic Lupus Erythematosus Patients and Controls Without Previous Cardiovascular Events
    Mara Taraborelli, Edoardo Sciatti, Ivano Bonadei, Vincenzo Terlizzi, Micaela Fredi, Roberta Zani, Giovanni Carlo Cancarini, Anǵela Tincani, Franco Franceschini, Enrico Vizzardi et al. · 2017 · Arthritis Care & Research
90. Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial
    Chi Chiu Mok, Kwok Hung Chan, Ling Yin Ho, Yim Fong Fung, Wai Fong Fung, Patrick C. Y. Woo · 2019 · Annals of the Rheumatic Diseases
91. Serum high-mobility group box 1 is correlated with interferon-α and may predict disease activity in patients with systemic lupus erythematosus
    Akihiro Tanaka, Tomoki� Ito, Kayoko Kibata, Noriko Inagaki‐Katashiba, Hideki Amuro, Tohru Nishizawa, Yonsu Son, Yoshio Ozaki, Shosaku� Nomura · 2019 · Lupus
92. Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus
    Ananta Subedi, Laurence S. Magder, Michelle Petri · 2015 · Rheumatology International
93. Systemic Lupus Erythematosus
    Chaim Putterman, Roberto Caricchio, Anne Davidson, Harris Perlman · 2012 · Clinical and Developmental Immunology
94. Remission and withdrawal of therapy in lupus nephritis
    Moroni, Gabriella, Raffiotta, Francesca, Ponticelli, Claudio · 2016 · Journal of Nephrology
95. Evaluating the Construct of Damage in Systemic Lupus Erythematosus
    Sindhu R. Johnson, Dafna D. Gladman, Hermine I. Brunner, David Alan Isenberg, Ann Elaine Clarke, Megan R.W. Barber, Laurent Arnaud, Paul R. Fortin, Marta Mosca, Alexandre E. Voskuyl et al. · 2021 · Arthritis Care & Research
96. Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus
    Spencer C Ding, Rebecca W.Y. Chan, Wenlei Peng, Liangbo Huang, Ze Zhou, Xi Hu, Stefano Volpi, Linda T. Hiraki, Augusto Vaglio, Paride Fenaroli et al. · 2022 · Clinical Chemistry
97. Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
    Maria Lucia Specchia, Chiara de Waure, Maria Rosaria Gualano, Andrea Doria, Giuseppe Turchetti, Lara Pippo, Francesco Di Nardo, Silvio Capizzi, Chiara Cadeddu, Flavia Kheiraoui et al. · 2014 · BioMed Research International
98. An Integrated Peptide-Antigen Microarray on Plasmonic Gold Films for Sensitive Human Antibody Profiling
    Bo Zhang, Justin A. Jarrell, Jordan V. Price, Scott M. Tabakman, Yanguang Li, Ming Gong, Guosong Hong, Ju Feng, Paul J. Utz, Hongjie Dai · 2013 · PLoS ONE
99. Validation of different sets of criteria for the diagnosis of Sjögren’s syndrome in Japanese patients
    Hiroto Tsuboi, Shinya Hagiwara, Hiromitsu Asashima, Hisanori Umehara, Atsushi Kawakami, Hideki Nakamura, Hajime Sano, Kazuo Tsubota, Yoko Ogawa, Etsuko Takamura et al. · 2012 · Modern Rheumatology
100. Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy
     Qiuyu Li, Feng Yu, Fude Zhou, Ming‐Hui Zhao · 2016 · Medicine